A phase II trial of risk-adapted treatment for muscle invasive bladder cancer after neoadjuvant accelerated MVAC
Publication/Presentation Date
2-2018
Volume
36
Issue
6
Published In/Presented At
Disciplines
Medicine and Health Sciences | Oncology
Department(s)
Department of Radiation Oncology
Document Type
Article
COinS